21.92
price up icon3.79%   0.80
after-market Handel nachbörslich: 21.92
loading

Ideaya Biosciences Inc Aktie (IDYA) Neueste Nachrichten

pulisher
Jun 17, 2025

Rhumbline Advisers Increases Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Holdings Lifted by GAMMA Investing LLC - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Handelsbanken Fonder AB Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on IDYA FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Transcript : IDEAYA Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 08, 2025
pulisher
Jun 02, 2025

IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events - Longview News-Journal

Jun 02, 2025
pulisher
Jun 02, 2025

IDEAYA Biosciences CEO Set for Major Healthcare Conference Double-Header: Jefferies and Goldman Sachs - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress

May 31, 2025
pulisher
May 30, 2025

Ideaya Biosciences announces inducement grants under Nasdaq listing rule - TipRanks

May 30, 2025
pulisher
May 30, 2025

IDEAYA Biosciences (IDYA) Grants Stock Options to New Employees | IDYA Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Nuveen Asset Management LLC - Defense World

May 30, 2025
pulisher
May 25, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $66.00 - Defense World

May 25, 2025
pulisher
May 25, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $54.27 Consensus PT from Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

(IDYA) Proactive Strategies - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

JP Morgan Raises Price Target for IDEAYA Biosciences (IDYA) | ID - GuruFocus

May 22, 2025
pulisher
May 22, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Acquired by Ameriprise Financial Inc. - Defense World

May 22, 2025
pulisher
May 21, 2025

BNP Paribas Financial Markets Buys 10,543 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 21, 2025
pulisher
May 20, 2025

Jane Street Group LLC Reduces Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 20, 2025
pulisher
May 20, 2025

Bank of America Corp DE Acquires 41,390 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 20, 2025
pulisher
May 15, 2025

January 2026 Options Now Available For IDEAYA Biosciences - Nasdaq

May 15, 2025
pulisher
May 14, 2025

Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849 (NASDAQ:IDYA) - Seeking Alpha

May 14, 2025
pulisher
May 12, 2025

(IDYA) Investment Analysis - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for IDYA Cut by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Stifel Financial Corp Sells 3,834 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 12, 2025
pulisher
May 11, 2025

Dimensional Fund Advisors LP Has $8.91 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 11, 2025
pulisher
May 10, 2025

16,769 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Raymond James Financial Inc. - Defense World

May 10, 2025
pulisher
May 10, 2025

Brokers Issue Forecasts for IDYA Q2 Earnings - Defense World

May 10, 2025
pulisher
May 10, 2025

Leerink Partnrs Has Bullish Estimate for IDYA Q2 Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, Her2-, BRCA1/2 mutant Breast Cancer - Barchart.com

May 09, 2025
pulisher
May 07, 2025

Ideaya Biosciences (IDYA) Faces Market Reaction Following FDA Le - GuruFocus

May 07, 2025
pulisher
May 07, 2025

IDEAYA Biosciences Reports Q1 2025 Financial Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Shares Down 10.2% After Earnings Miss - Defense World

May 07, 2025
pulisher
May 06, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by Mariner LLC - Defense World

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - The Malaysian Reserve

May 06, 2025
pulisher
May 06, 2025

IDEAYA Gets FDA Clearance to Initiate Clinical Trial of Antibody Drug Conjugate Program in Solid Tumors - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Posts Q1 Net Loss; Cash Runway Extended Through 2029 - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA gets approval to begin trial for its antibody drug conjugate in solid tumors - Seeking Alpha

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Ideaya Biosciences (IDYA) Achieves Major Milestones in Oncology Programs | IDYA Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Ideaya Biosciences (IDYA) Advances with FDA Approval for IDE849 Trial | IDYA Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

FDA clears IDEAYA’s Phase 1 trial for new cancer drug By Investing.com - Investing.com South Africa

May 06, 2025
pulisher
May 06, 2025

FDA clears IDEAYA’s Phase 1 trial for new cancer drug - Investing.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors – Company Announcement - Financial Times

May 06, 2025
pulisher
May 05, 2025

IDEAYA Receives Fast Track Designation for Potential First-in-Class PARG Inhibitor, IDE161, for Treatment of Pretreated, Platinum-Resistant Advanced or Metastatic Ovarian Cancer Patients having tumors with BRCA1/2 Mutations - Barchart.com

May 05, 2025
pulisher
May 05, 2025

IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib Combination in GNAQ/11 Metastatic Cutaneous Melanoma - Barchart.com

May 05, 2025
pulisher
May 05, 2025

Why IDEAYA Biosciences, Inc. (IDYA) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential - Insider Monkey

May 05, 2025
pulisher
May 04, 2025

IDEAYA Biosciences (IDYA) to Release Quarterly Earnings on Tuesday - Defense World

May 04, 2025
pulisher
May 03, 2025

Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey

May 03, 2025
pulisher
May 02, 2025

Trading (IDYA) With Integrated Risk Controls - news.stocktradersdaily.com

May 02, 2025
pulisher
May 01, 2025

Invesco Ltd. Has $1.46 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Nothing is Better Than Ideaya Biosciences Inc (IDYA) stock at the moment - Sete News

Apr 30, 2025
pulisher
Apr 29, 2025

Ideaya Biosciences Inc (IDYA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

IDYA (Ideaya Biosciences Inc) has impressive results - uspostnews.com

Apr 29, 2025
pulisher
Apr 28, 2025

Investing in Ideaya Biosciences Inc (IDYA): What You Must Know - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

IDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations Events - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Ideaya Biosciences Inc (NASDAQ: IDYA) Stock Forecast: An Analysis - Marketing Sentinel

Apr 28, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):